CardioGenics Enters Into Binding Letter of Intent to Acquire Assets of Ontario-Based Plasticap
Marketwired - Mon Oct 05, 8:01AM CDT
CardioGenics Holdings Inc. (OTCQB: CGNH), developer of the ultra-sensitive QL Care(TM) analyzer, an immunoassay point-of-care analyzer, and other products for the In-Vitro-Diagnostics ("IVD"
CardioGenics Enters Into Manufacturing Agreement With Ontario-Based Plasticap
Marketwired - Tue Aug 25, 8:02AM CDT
CardioGenics Holdings Inc. (OTCQB: CGNH), developer of the ultra-sensitive QL Care(TM) analyzer, an immunoassay point-of-care analyzer, and other products for the In-Vitro-Diagnostics ("IVD"
USPTO Issues Notice of Allowance in Connection With CardioGenics' Self-Metering Cartridge Patent Application
GlobeNewswire - Tue Feb 17, 8:50AM CST
CardioGenics Holdings Inc. (OTCQB:CGNH), developer of the ultra-sensitive QL Care(TM) analyzer, an immunoassay point-of-care analyzer, and other products for the In-Vitro-Diagnostics ("IVD"
InsiderInsights.com Daily Round Up 2/11/15: GRUB, FSC, RENT, SXC
InsiderInsights - at Seeking Alpha - Thu Feb 12, 11:02AM CST
GRA: 98.00 (-0.26), GRUB: 30.18 (+0.22), SXC: 9.75 (+0.12), RENT: 60.85 (+0.16), ASPX: 100.96 (unch), BH: 366.93 (-6.65), NOW: 74.42 (+1.40), FSC: 6.40 (-0.07), NWL: 42.22 (-0.20), AST: 4.70 (-0.01), AVNU: 13.70 (-0.27), WDR: 34.58 (-0.42), DATA: 83.00 (+3.44), CRM: 75.25 (+0.16)
CardioGenics Announces Appointment of New Director
GlobeNewswire - Mon Jan 12, 3:30PM CST
CardioGenics Holdings Inc. (OTCQB:CGNH), developer of the ultra-sensitive QL Care(TM) analyzer, an immunoassay point-of-care analyzer, and other products for the In-Vitro-Diagnostics testing market, announced today that Karim Murabet has been appointed as a director of the Company, effective January 12, 2015. Mr. Murabet will serve as an independent director.